Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May act as a receptor in regulating T-cell proliferation.. Additionally we are shipping CD5 Proteins (19) and CD5 Kits (15) and many more products for this protein.
Showing 10 out of 903 products:
Human Monoclonal CD5 Primary Antibody for IHC (p) - ABIN1687421
Galgani, Insabato, Calì, Della Gatta, Mirra, Papaccio, Santopaolo, Alviggi, Mollo, Strina, Matarese, Beguinot, De Placido, Ulianich: Regulatory T cells, inflammation, and endoplasmic reticulum stress in women with defective endometrial receptivity. in Fertility and sterility 2015
Show all 21 references for ABIN1687421
Rat (Rattus) Monoclonal CD5 Primary Antibody for FACS, IHC (fro) - ABIN120388
Dallman, Thomas, Green: MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses. in European journal of immunology 1984
Show all 4 references for ABIN120388
Rat (Rattus) Monoclonal CD5 Primary Antibody for FACS - ABIN120386
Barclay: The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. in Immunology 1981
Show all 3 references for ABIN120386
Human Monoclonal CD5 Primary Antibody for FACS - ABIN951342
Raman, Kuo, Deshane, Litchfield, Kimberly: Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5. in The Journal of biological chemistry 1998
Show all 3 references for ABIN951342
Human Monoclonal CD5 Primary Antibody for IHC (fro), IHC (p) - ABIN114633
Kasaian, Ikematsu, Casali: CD5+ B lymphocytes. in Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1991
Show all 2 references for ABIN114633
Human Monoclonal CD5 Primary Antibody for FACS, IHC (p) - ABIN1106434
Wang, Kvalheim, Kvaløy, Beiske, Jakobsen, Wijdenes, Pihl, Fodstad: An effective immunomagnetic method for bone marrow purging in T cell malignancies. in Bone marrow transplantation 1992
Human Polyclonal CD5 Primary Antibody for WB - ABIN2774224
Garza-Garcia, Esposito, Rieping, Harris, Briggs, Brown, Driscoll: Three-dimensional solution structure and conformational plasticity of the N-terminal scavenger receptor cysteine-rich domain of human CD5. in Journal of molecular biology 2008
Mouse (Murine) Monoclonal CD5 Primary Antibody for FACS - ABIN120102
Cobbold, Jayasuriya, Nash, Prospero, Waldmann: Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. in Nature 1985
Human Monoclonal CD5 Primary Antibody for FACS - ABIN1106444
Garnache-Ottou, Chaperot, Biichle, Ferrand, Remy-Martin, Deconinck, de Tailly, Bulabois, Poulet, Kuhlein, Jacob, Salaun, Arock, Drenou, Schillinger, Seilles, Tiberghien, Bensa, Plumas, Saas: Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. in Blood 2005
In mouse tumor models, CD5(+) but not CD5(-) B cells promoted tumor growth. The results demonstrate a critical role of CD5(+) B cells in promoting cancer.
CD5 and CD72 (show CD72 Antibodies) play a critical role in maintaining regulatory T and B cell homeostasis
CD5 promoted Treg cell induction in response to self and tolerizing antigens by blocking mTOR (show FRAP1 Antibodies) activation.
Data indicate that CD5-casein kinase 2 (CK2 (show CSNK2A1 Antibodies)) signaling is necessary for efficient nuclear localization of orphan nuclear receptor (show NR1D1 Antibodies) ROR (show RORB Antibodies)-gammaT (RORgammat).
These results support the notion that the distal cytoplasmic domain of CD5, including Y463, plays a relevant role in the downmodulation of TCR signals in thymocytes via c-Cbl (show CBL Antibodies).
Although the percentage of CD1d (show CD1D Antibodies)(hi)CD5+ subset in splenic B cells does not change significantly, percent IL-10 (show IL10 Antibodies)-expressing cells among total splenic B cells or the CD1dhiCD5+ population significantly increases 3-7 days after rCRT/39-272 administration
Different CD5 expression levels influence the proliferation dynamics of activated naive CD4 (show CD4 Antibodies)+ T cells while leaving the conversion rate of those cells into memory cells unaffected.
Data show several homologies across human, rat and mouse in the kinetic of loss of several LAgs such as CD5, CD4 (show CD4 Antibodies) and CD28 (show CD28 Antibodies).
CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn (show FYN Antibodies) kinase
Delayed tumor growth in CD5-deficient mice is associated with enhanced activation of tumor-infiltrating lymphocytes due to an upregulated T cell response to T cell receptor (TCR) stimulation.
This study confirms the poor prognosis of de novo CD5+ DLBCL in a large multi-center cohort despite initial rituximab-containing chemotherapy and suggests that stem cell transplantation fails to salvage the majority of these patients.
5.2 % were positive for CD5 and 5.7 % positive for epstein-Barr virus encoded RNA
CD5 polymorphisms are associated with systemic lupus erythematosus.
three tyrosine-based domains within CD5 cytoplasmic tail promote T-cell survival through non-overlapping mechanisms
A case of mantle cell lymphoma with a unique pattern of CD5 negative to positive expression switching in relapse.
Data show that the proportion of CD5+ B cells at 1 mo of age is inversely correlated to total IgG levels at 18 and 36 mo of age.
down-regulation of CD5 on activated CD8 (show CD8A Antibodies)(+) T cells may serve as a useful marker of dysregulated T cell activation and proliferation in FHL2 (show FHL2 Antibodies).
CD5 expression in nodal marginal zone lymphoma correlates with a higher frequency of dissemination, but patients have an indolent clinical course and excellent overall survival.
Our results indicate that CD5(+) B cell subsets might be associated with pathogenesis of SPMS.
Functional CD5-dependent casein kinase 2 signaling is necessary in a CD5 knock-in mouse for efficient differentiation of naive CD4 (show CD4 Antibodies)+ T cells into T helper (Th)2 and Th17 cells, but not Th1 (show TH1L Antibodies)-type cells.
Findings suggest that development, selection and function of different B- and T-cell subsets may be directly or indirectly dependent on different glycan structures associated with CD5 or CD5-like (show CD5L Antibodies) molecules expressed on T cells compared to B (show TDO2 Antibodies) cells.
May act as a receptor in regulating T-cell proliferation.
, t-cell surface glycoprotein CD5-like
, T-cell surface glycoprotein CD5
, lymphocyte antigen 1
, CD5 antigen (p56-62)
, lymphocyte antigen T1/Leu-1
, CD5 antigen
, Lymphocyte antigen CD5
, CD74 antigen, invariant polypeptide of major
, lymphocyte receptor CD5